[1] SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023[J].CA Cancer J Clin,2023,73(1):17-48.
[2]ANWANWAN D,SINGH SK,SINGH S,et al.Challenges in liver cancer and possible treatment approaches[J].Biochim Biophys Acta Rev Cancer,2020,1873(1):188314.
[3] KUDO M,UESHIMA K,CHAN S,et al.Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and child-pugh a liver function:a proof-of-concept study[J].Cancers (Basel),2019,11(8):1084.
[4] HAMAYA S,OURA K,MORISHITA A,et al.Cisplatin in liver cancer therapy[J].Int J Mol Sci,2023,24(13):10858.
[5] NALBANTOGLU IL,TAN BR JR,LINEHAN DC,et al.Histological features and severity of oxaliplatin-induced liver injury and clinical associations[J].J Dig Dis,2014,15(10):553-560.
[6] TANG W,CHEN Z,ZHANG W,et al.The mechanisms of sorafenib resistance in hepatocellular carcinoma:theoretical basis and therapeutic aspects[J].Signal Transduct Target Ther,2020,5(1):87.
[7] LIU Z,LIU X,LIANG J,et al.Immunotherapy for hepatocellular carcinoma:current status and future prospects[J].Front Immunol,2021,12:765101.
[8]GURUNG S,PEROCHEAU D,TOURAMANIDOU L,et al.The exosome journey:from biogenesis to uptake and intracellular signalling[J].Cell Commun Signal,2021,19(1):47.
[9]LI B,CAO Y,SUN M,et al.Expression,regulation,and function of exosome-derived miRNAs in cancer progression and therapy[J].FASEB J,2021,35(10):e21916.
[10]MOON B,CHANG S.Exosome as a delivery vehicle for cancer therapy[J].Cells,2022,11(3):316.
[11]DAD HA,GU TW,ZHU AQ,et al.Plant exosome-like nanovesicles:emerging therapeutics and drug delivery nanoplatforms[J].Mol Ther,2021,29(1):13-31.
[12]王刚,才谦,李三华,等.石上柏双黄酮类和酚酸类成分体外抗氧化和抗肿瘤活性研究[J].辽宁中医药大学学报,2018,20(07):5-8.
WANG G,CAI Q,LI SH,et al.Studyon antioxidant and antitumor activity of biflavonoids and phenolic acids from selaginella doederleinii in vitro[J].Journal of Liaoning University of TCM,2018,20(07):5-8.
[13]武乐,黄淑娟,余腾骅,等.基于网络药理学与分子对接技术探讨石上柏在治疗癌症中的作用机制[J].实用癌症杂志,2022,37(12):1961-1966.
WU L,HUANG SJ,YU TH,et al.Study on the mechanism of Selaginella doederleinii Hieron in treating cancer based on network pharmacology and molecular docking technology[J].The Practical Journal of Cancer,2022,37(12):1961-1966.
[14]李万东,霍斌亮,吴姝涵,等.参芪扶正注射液对三阴性乳腺癌新辅助化疗的增效减毒效果[J].中国药物与临床,2023,23(02):69-73.
LI WD,HUO BL,WU SH,et al.Shenqi Fuzheng Injection increases efficacy and reduces toxicity of neoadjuvant chemotherapy for triple negative breast cancer:a mechanistic study[J].Chinese Remedies & Clinics,2023,23(02):69-73.
[15]王航天,何娜,朱婧,等.小柴胡汤对化疗的增效减毒作用研究进展[J].中南药学,2023,21(08):2151-2157.
WANG HT,HE N,ZHU J,et al.Research progress in synergismtic effect of Xiaochaihu decoction on chemotherapy and toxicity reducation[J].Central South Pharmacy,2023,21(08):2151-2157.
[16]王子健,周春阳,蒋树龙,等.中医药减毒增效作用在肿瘤放射治疗中的应用进展[J].中华中医药杂志,2023,38(08):3732-3735.
WANG ZJ,ZHOU CY,JIANG SL,et al.Application progress on toxicity reduction and efficacy enhancement of traditional Chinese medicine in cancer radiotherapy[J].China Journal of Traditional Chinese Medicine and Pharmacy,2023,38(08):3732-3735.
[17]张烨,金志超,徐媛媛.归芍六君子汤对晚期胃癌Th1/Th2免疫漂移及临床疗效的影响[J].现代肿瘤医学,2023,31(15):2867-2872.
ZHANG Y,JIN ZC,XU YY.Effect of Guishao Liujunzi decoction on Th1/Th2 immune drift and clinical efficacy in advanced gastric cancer[J].Modern Oncology,2023,31(15):2867-2872.
[18]龚修云,金风,吴伟莉,等.复方斑蝥注射液联合放化疗治疗局部晚期鼻咽癌的疗效及不良反应[J].现代肿瘤医学,2021,29(18):3172-3177.
GONG XY,JIN F,WU WL,et al.Efficacy and adverse reactions of compound cantharidin injection combined with radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma[J].Modern Oncology,2021,29(18):3172-3177.
[19] CHEN Q,LI Q,LIANG Y,et al.Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation[J].Acta Pharm Sin B,2022,12(2):907-923.
[20]REZAIE J,FEGHHI M,ETEMADI T.A review on exosomes application in clinical trials:perspective,questions,and challenges[J].Cell Commun Signal,2022,20(1):145.
[21]RAIMONDO S,NASELLI F,FONTANA S,et al.Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death[J].Oncotarget,2015,6(23):19514-19527.
[22]ZHANG L,HE F,GAO L,et al.Engineering exosome-like nanovesicles derived from asparagus cochinchinensis can inhibit the proliferation of hepatocellular carcinoma cells with better safety profile[J].Int J Nanomedicine,2021,16:1575-1586.
[23]LU X,HAN Q,CHEN J,et al.Celery (Apium graveolens L.)exosome-like nanovesicles as a new-generation chemotherapy drug delivery platform against tumor proliferation[J].J Agric Food Chem,2023,71(22):8413-8424.
[24]KIM J,LI S,ZHANG S,et al.Plant-derived exosome-like nanoparticles and their therapeutic activities[J].Asian J Pharm Sci,2022,17(1):53-69.
[25]ZHANG Z,YU Y,ZHU G,et al.The emerging role of plant-derived exosomes-like nanoparticles in immune regulation and periodontitis treatment[J].Front Immunol,2022,13:896745.
[26]OU X,WANG H,TIE H,et al.Novel plant-derived exosome-like nanovesicles from catharanthus roseus:preparation,characterization,and immunostimulatory effect via TNF-α/NF-κB/PU.1 axis[J].J Nanobiotechnology,2023,21(1):160.
[27]SUHARTA S,BARLIAN A,HIDAJAH AC,et al.Plant-derived exosome-like nanoparticles:a concise review on its extraction methods,content,bioactivities,and potential as functional food ingredient[J].J Food Sci,2021,86(7):2838-2850.
[28]SALL IM,FLAVIU TA.Plant and mammalian-derived extracellular vesicles:a new therapeutic approach for the future[J].Front Bioeng Biotechnol,2023,11:1215650.
[29]TENG Y,REN Y,SAYED M,et al.Plant-derived exosomal microRNAs shape the gut microbiota[J].Cell Host Microbe,2018,24(5):637-652.
[30]LIU J,XIANG J,JIN C,et al.Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression[J].J Nanobiotechnology,2023,21(1):78.